Five Prime Therapeutics: 3Q Earnings Snapshot

November 6, 2019

SOUTH SAN FRANCISCO, Calif. (AP) _ Five Prime Therapeutics Inc. (FPRX) on Wednesday reported a loss of $36.1 million in its third quarter.

The South San Francisco, California-based company said it had a loss of $1.03 per share.

The results missed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 95 cents per share.

The biotech company that develops treatments targeting cancer and autoimmune diseases posted revenue of $3 million in the period, which also fell short of Street forecasts. Five analysts surveyed by Zacks expected $4.3 million.

In the final minutes of trading on Wednesday, the company’s shares hit $4.01. A year ago, they were trading at $12.11.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FPRX at https://www.zacks.com/ap/FPRX